B-cell-activating factor (BAFF), alternatively called a B-lymphocyte stimulator (BLyS), is a potent modulator of B-cell differentiation and has been previously targeted in MS patients [135,136]. This evidence concerns the gene TNFSF13B and myeloid sarcoma.